These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. Lipshultz SE; Miller TL; Scully RE; Lipsitz SR; Rifai N; Silverman LB; Colan SD; Neuberg DS; Dahlberg SE; Henkel JM; Asselin BL; Athale UH; Clavell LA; Laverdière C; Michon B; Schorin MA; Sallan SE J Clin Oncol; 2012 Apr; 30(10):1042-9. PubMed ID: 22370326 [TBL] [Abstract][Full Text] [Related]
3. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers. Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD; AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305 [TBL] [Abstract][Full Text] [Related]
5. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging. Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440 [TBL] [Abstract][Full Text] [Related]
6. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Apple FS; Murakami MM; Pearce LA; Herzog CA Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888 [TBL] [Abstract][Full Text] [Related]
7. Association of high-sensitivity cardiac troponin T and N-terminal pro-brain-type natriuretic peptide with left ventricular structure: J-HOP study. Hoshide S; Nagai M; Yano Y; Ishikawa J; Eguchi K; Kario K; J Clin Hypertens (Greenwich); 2014 May; 16(5):354-61. PubMed ID: 24811391 [TBL] [Abstract][Full Text] [Related]
9. Myocardial peak systolic velocity-a tool for cardiac screening of HIV-exposed uninfected children. Martins P; Pires A; Albuquerque ME; Oliveira-Santos M; Santos J; Sena C; Seiça R Eur J Pediatr; 2020 Mar; 179(3):395-404. PubMed ID: 31761972 [TBL] [Abstract][Full Text] [Related]
10. Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children. Wilkinson JD; Williams PL; Yu W; Colan SD; Mendez A; Zachariah JPV; Van Dyke RB; Shearer WT; Margossian RE; Lipshultz SE; AIDS; 2018 Jun; 32(10):1267-1277. PubMed ID: 29596110 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403 [TBL] [Abstract][Full Text] [Related]
12. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy. Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658 [TBL] [Abstract][Full Text] [Related]
13. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study. Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614 [TBL] [Abstract][Full Text] [Related]
14. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of N-terminal prohormone of brain natriuretic peptide and cardiac troponin-I levels in cats with systolic anterior motion of the mitral valve in the absence of left ventricular hypertrophy. Ferasin L; Kilkenny E; Ferasin H J Vet Cardiol; 2020 Aug; 30():23-31. PubMed ID: 32645686 [TBL] [Abstract][Full Text] [Related]
16. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study. Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism. Choi HS; Kim KH; Yoon HJ; Hong YJ; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC; Kang JC J Cardiol; 2012 Dec; 60(6):508-13. PubMed ID: 22902901 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal patterns of N-terminal pro B-type natriuretic peptide, troponin T, and C-reactive protein in relation to the dynamics of echocardiographic parameters in heart failure patients. Klimczak-Tomaniak D; van den Berg VJ; Strachinaru M; Akkerhuis KM; Baart S; Caliskan K; Manintveld OC; Umans V; Geleijnse M; Boersma E; van Dalen BM; Kardys I Eur Heart J Cardiovasc Imaging; 2020 Sep; 21(9):1005-1012. PubMed ID: 31596459 [TBL] [Abstract][Full Text] [Related]
19. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain. Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure. Gao Y; Xing C; Hao W; Zhao H; Wang L; Luan B; Hou A Int Heart J; 2020 Jan; 61(1):1-6. PubMed ID: 31875616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]